Skip to content
Clinical Trials – home

Centre Hospitalier General De Bastia

Verified siteinfo

France Chemin De Falconaja, 20600 Bastia, France

  • 1 trial recruiting
  • Sepsis · Muscle spasticity
  • Adults and children

About Specializations

Centre Hospitalier General De Bastia in Bastia, France specialises in clinical trials of conditions such as Sepsis, Muscle spasticity, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiology and Cardiovascular Research

The medical center is at the forefront of cardiology research, focusing on innovative treatments for acute myocarditis. This condition, characterized by inflammation of the heart muscle, can lead to severe complications if not addressed promptly.

  • Acute Myocarditis Management
  • Heart Failure Therapy
  • Cardiac Imaging Techniques

Through its research, the center is pioneering new therapeutic approaches, such as the use of corticosteroids in managing acute myocarditis, aiming to improve patient outcomes and reduce the incidence of major cardiovascular events.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Chemin De Falconaja20600 BastiaFrance
Recruiting now
1 trial
Conditions studied
2
Partner status
Verified site

More sites in BastiaFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Sepsis

Recruiting

Testing a Drug Combination for Personalized Sepsis Treatment in Children and Adults with Severe Blood Infection

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Methylprednisolone
  • Sponsor:Assistance Publique Hopitaux De Paris

Muscle spasticity

Not recruiting

Study on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A - Haemagglutinin Complex
  • Sponsor:Ipsen Innovation
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.